Table 5.
Group | Case Number | Percentage (%) |
---|---|---|
Proliferative phase endometrium | 143 | 15.07 |
Secretory phase endometrium | 95 | 10.01 |
Menstrual phase endometrium | 17 | 1.79 |
Exogenous hormones | 50 | 5.27 |
Menopausal endometrium | 41 | 4.32 |
Inadequate for analysis | 181 | 19.07 |
Endometrial polyp | 117 | 12.33 |
Endometrial hyperplasia | 253 | 26.66 |
Malignant tumors | 42 | 4.43 |
Endometritis | 10 | 1.05 |
Total | 949 | 100 |